Vaccination - PRD

 

 The Food and Drug Administration revealed that Johnson & Johnson's COVID-19 vaccine is requesting emergency use authorization in Thailand. 

So far, there are three companies that have requested the authorization: (1) AstraZeneca, which is already approved; (2) Sinovac, which is in the process of requesting; and (3) Johnson & Johnson, which is in the process of requesting. 

The emergency use authorization in the Kingdom has a period of use for one year, and the side effects after use must be followed up to evaluate its safety.

Source: ศูนย์ข้อมูล COVID-19